Logo image of 1MRNA.MI

MODERNA INC (1MRNA.MI) Stock Earnings & Estimates

Europe - BIT:1MRNA - US60770K1079 - Common Stock

23.9 EUR
-0.17 (-0.71%)
Last: 10/6/2025, 7:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
1MRNA.MI revenue by date.1MRNA.MI revenue by date.
19.263B
4.29%
6.848B
-64.45%
3.236B
-52.75%
1.962B
-39.37%
2.167B
10.45%
2.69B
24.13%
4.308B
60.15%
7.645B
77.46%
12.088B
58.12%
8.397B
-30.53%
9.513B
13.29%
EBITDA
YoY % growth
1MRNA.MI ebitda by date.1MRNA.MI ebitda by date.
9.768B
-27.79%
-1.418B
-114.52%
-3.261B
-129.97%
-3.958B
-21.39%
-3.085B
22.06%
-1.902B
38.34%
-217.26M
88.58%
1.342B
717.69%
2.216B
65.13%
3.073B
38.67%
3.916B
27.43%
EBIT
YoY % growth
1MRNA.MI ebit by date.1MRNA.MI ebit by date.
9.42B
-29.15%
-2.039B
-121.65%
-3.45B
-69.20%
-4.168B
-20.82%
-3.335B
19.99%
-2.226B
33.26%
-861.632M
61.29%
1.058B
222.79%
3.544B
234.97%
1.977B
-44.22%
2.814B
42.34%
Operating Margin
1MRNA.MI operating margin by date.1MRNA.MI operating margin by date.
48.90%-29.78%-106.61%-212.45%-153.90%-82.74%-20.00%13.84%29.32%23.54%29.58%
EPS
YoY % growth
1MRNA.MI eps by date.1MRNA.MI eps by date.
19.96
-29.45%
-12.41
-162.17%
-9.28
25.22%
-9.98
-7.53%
-8.07
19.11%
-5.43
32.67%
-1.76
67.53%
2.93
266.18%
7.69
162.12%
4.33
-43.69%
5.79
33.70%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-2.11
-7,126.10%
-2.97
-2.08%
-2.54
-0.65%
-2.60
-21.92%
-1.32
37.38%
-1.39
53.37%
Revenue
Q2Q % growth
924.35M
-50.36%
756.82M
-21.65%
164.02M
51.87%
98.889M
-30.36%
1.019B
10.24%
1.009B
33.32%
EBITDA
Q2Q % growth
-971.381M
-455.82%
-1.149B
-33.01%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-909.844M
-731.84%
-1.233B
-17.07%
-1.011B
-0.27%
-1.033B
-18.91%
-496.339M
45.45%
-596.29M
51.63%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-2.13
36.04%
-3.030.9029.60%
Q1 2025
Q2Q % growth
-2.52
17.92%
-3.200.6821.22%
Q4 2024
Q2Q % growth
-2.91
-629.09%
-2.74-0.17-6.26%
Q3 2024
Q2Q % growth
0.03
100.31%
-1.951.98101.54%
Q2 2024
Q2Q % growth
-3.33
8.01%
-3.450.123.51%
Q1 2024
Q2Q % growth
-3.07
-1,715.79%
-3.660.5916.04%
Q4 2023
Q2Q % growth
0.55
-84.76%
-0.991.54155.49%
Q3 2023
Q2Q % growth
-9.53
-476.68%
-1.97-7.56-384.77%
Q2 2023
Q2Q % growth
-3.62
-169.08%
-4.120.5012.15%
Q1 2023
Q2Q % growth
0.19
-97.79%
-1.812.00110.52%
Q4 2022
Q2Q % growth
3.61
-68.02%
4.77-1.16-24.31%
Q3 2022
Q2Q % growth
2.53
-67.14%
3.36-0.83-24.66%
Q2 2022
Q2Q % growth
5.24
-18.89%
4.640.6012.94%
Q1 2022
Q2Q % growth
8.58
202.11%
5.323.2661.43%
Q4 2021
Q2Q % growth
11.29
1,736.23%
10.101.1911.80%
Q3 2021
Q2Q % growth
7.70
1,405.08%
9.23-1.53-16.58%
Q2 2021
Q2Q % growth
6.46
2,183.87%
6.070.396.35%
Q1 2021
Q2Q % growth
2.84
911.43%
2.430.4116.66%
Q4 2020
Q2Q % growth
-0.69
-86.49%
-0.35-0.34-95.61%
Q3 2020
Q2Q % growth
-0.59
-59.46%
-0.43-0.16-35.84%
Q2 2020
Q2Q % growth
-0.31
24.39%
-0.360.0513.37%
Q1 2020
Q2Q % growth
-0.35
12.50%
-0.360.012.79%
Q4 2019
Q2Q % growth
-0.37 -0.430.0613.63%
Q3 2019
Q2Q % growth
-0.37 -0.440.0715.31%
Q2 2019
Q2Q % growth
-0.41 -0.450.048.65%
Q1 2019
Q2Q % growth
-0.40 -0.37-0.03-7.65%
1MRNA.MI Yearly EPS VS Estimates1MRNA.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 10 -10 20
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
142M
-41.08%
115.2M26.8M23.26%
Q1 2025
Q2Q % growth
108M
-35.33%
108.32M-320K-0.30%
Q4 2024
Q2Q % growth
966M
-65.64%
961.7M4.3M0.45%
Q3 2024
Q2Q % growth
1.862B
1.69%
1.275B587M46.04%
Q2 2024
Q2Q % growth
241M
-29.94%
134.83M106.17M78.74%
Q1 2024
Q2Q % growth
167M
-91.03%
99.451M67.549M67.92%
Q4 2023
Q2Q % growth
2.811B
-44.71%
2.545B266M10.45%
Q3 2023
Q2Q % growth
1.831B
-45.57%
1.432B399M27.86%
Q2 2023
Q2Q % growth
344M
-92.76%
326.03M17.97M5.51%
Q1 2023
Q2Q % growth
1.862B
-69.30%
1.202B660M54.91%
Q4 2022
Q2Q % growth
5.084B
-29.50%
5.118B-34M-0.66%
Q3 2022
Q2Q % growth
3.364B
-32.30%
3.597B-233M-6.48%
Q2 2022
Q2Q % growth
4.749B
9.07%
4.147B602M14.52%
Q1 2022
Q2Q % growth
6.066B
213.16%
4.709B1.357B28.82%
Q4 2021
Q2Q % growth
7.211B
1,163.54%
6.928B283M4.08%
Q3 2021
Q2Q % growth
4.969B
3,046.93%
6.331B-1.362B-21.51%
Q2 2021
Q2Q % growth
4.354B
6,457.23%
4.292B62M1.44%
Q1 2021
Q2Q % growth
1.937B
22,959.52%
2.078B-141M-6.79%
Q4 2020
Q2Q % growth
570.7M
3,947.52%
285M285.7M100.25%
Q3 2020
Q2Q % growth
157.9M
828.82%
79.063M78.837M99.71%
Q2 2020
Q2Q % growth
66.4M
406.87%
27.977M38.423M137.34%
Q1 2020
Q2Q % growth
8.4M
-47.50%
17.432M-9.032M-51.81%
Q4 2019
Q2Q % growth
14.1M 17.721M-3.621M-20.43%
Q3 2019
Q2Q % growth
17M 18.725M-1.725M-9.21%
Q2 2019
Q2Q % growth
13.1M 19.176M-6.076M-31.69%
Q1 2019
Q2Q % growth
16M 32.742M-16.742M-51.13%
1MRNA.MI Yearly Revenue VS Estimates1MRNA.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS1.24% -13.33% -0.01% 3.49%
Revenue-0.74% -22.52% -0.25% -8.1%